First Squawk(@FirstSquawk):AbbVie Q3 2026 Earnings - Q3 Adj EPS: $3.82 (est $3.74) - Humira Rev: $683M (est $679.3M) - Skyrizi Rev: $5.78B (est $5.74B) - Net Rev: $17.40B (est $17.34B) - Imbruvica Rev: $522M (est $527.3M) - Rinvoq Rev: $2.71B (est $2.7B) - Sees FY Adj EPS: $13.95 To $13.99 (prev guidance $13.76 To $13.96)

First Squawk

@FirstSquawk

Firstsquawk Is a Global Financial (News) Squawk Service Specialising In Financial Markets, Macro, Geopolitics,politics

加入 July 2015

252 正在關注 578.9K 粉絲

First Squawk@FirstSquawk

2026.10.30 11:48

AbbVie Q3 2026 Earnings - Q3 Adj EPS: $3.82 (est $3.74) - Humira Rev: $683M (est $679.3M) - Skyrizi Rev: $5.78B (est $5.74B) - Net Rev: $17.40B (est $17.34B) - Imbruvica Rev: $522M (est $527.3M) - Rinvoq Rev: $2.71B (est $2.7B) - Sees FY Adj EPS: $13.95 To $13.99 (prev guidance $13.76 To $13.96)